Lv3
380 积分 2022-11-19 加入
Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
1个月前
已完结
Surgical treatment of upper gastrointestinal bleeding in patients with portal hypertension and portal vein thrombosis
6个月前
已关闭
Risk factors for portal vein thrombosis in cirrhotic patients and the influences of anticoagulation on esophagogastric variceal bleeding
6个月前
已关闭
Immunology and immunotherapy of cholangiocarcinoma
1年前
已完结
Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization
1年前
已完结
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
1年前
已完结
Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model
1年前
已完结
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
1年前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
1年前
已完结
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy
2年前
已完结
皖公网安备34019202002308
